Aditx Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Aditx Therapeutics, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ADITXT and ADITXTSCORE. The owner is based in Mountain View, CA.
2569 Wyandotte St., Suite 101
Mountain View, CA 94043
Showing of trademarks Trademarks
Trademark Classifications
Aditx Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Aditx Therapeutics, Inc. have?
Aditx Therapeutics, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 6 abandoned.
What trademark classes does Aditx Therapeutics, Inc. file in?
Aditx Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Aditx Therapeutics, Inc.'s most well-known trademarks?
Aditx Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as ADITXT and ADITXTSCORE. These are among 2 currently registered trademarks in the portfolio.
What is Aditx Therapeutics, Inc.'s trademark registration success rate?
Aditx Therapeutics, Inc. has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.